Laureate Education, Inc., together with its subsidiaries, offers higher education programs and services to students through a portfolio of higher education institutions in Mexico, Peru, and the United States.
Screened 2026-08-25 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Laureate Education, Inc. holds its Accumulation at $38.36. Consolidating, no directional conviction, held for 19 days.
As held on the ledger · 2026-08-25
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 19 days
Price at the screen
$38.36
Valuation
17.36 trailing · 15.78 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.45
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.36%
Below 33%
Interest-bearing debt is just 23.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
17.71%
Below 49%
Money owed to the company is 17.7% of assets, under the 49% limit.
Pass
Revenue purity
0.42%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-25 screen. The gold marker is the market price at the same screen. A 16.8% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +7% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-25 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Education provider growing fast but lacks clear edge
Think of a student in Lima or Mexico City signing up for a degree that could lift their earnings for life. Laureate runs those institutions across three countries and is seeing revenue climb 15 percent while posting a 16 percent profit margin and 29 percent return on equity. At 14.7 times forward earnings the shares sit below our $43 fair value with an 18 percent margin of safety, yet the opportunity rating stays at none because the moat is unknown.
The business clears our ethical screen without flags, and six analysts point to a $40 median target. Numbers look steady for a defensive education name, but the absence of a visible competitive barrier keeps us from getting excited even when growth and cash returns appear solid.
Risks centre on regulatory shifts in Mexico and Peru plus currency swings that can hit reported results quickly. Unknown moat means any edge could erode faster than the numbers suggest. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LAUR trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-04Markup$38.31+4.2%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-07-18Markup$36.76+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 67%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it none, with a mean price target of $40.
2026-07-03Markup$36.76+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$36.76Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
